A detailed history of Granahan Investment Management, LLC transactions in 10x Genomics, Inc. stock. As of the latest transaction made, Granahan Investment Management, LLC holds 334,007 shares of TXG stock, worth $5.4 Million. This represents 0.27% of its overall portfolio holdings.

Number of Shares
334,007
Previous 178,893 86.71%
Holding current value
$5.4 Million
Previous $6.71 Million 3.23%
% of portfolio
0.27%
Previous 0.24%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$19.45 - $37.37 $3.02 Million - $5.8 Million
155,114 Added 86.71%
334,007 $6.5 Million
Q1 2024

May 15, 2024

SELL
$36.08 - $54.3 $222,288 - $334,542
-6,161 Reduced 3.33%
178,893 $6.71 Million
Q4 2023

Feb 14, 2024

BUY
$34.32 - $57.55 $6.35 Million - $10.6 Million
185,054 New
185,054 $10.4 Million

Others Institutions Holding TXG

About 10x Genomics, Inc.


  • Ticker TXG
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 95,046,400
  • Market Cap $1.54B
  • Description
  • 10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumabl...
More about TXG
Track This Portfolio

Track Granahan Investment Management, LLC Portfolio

Follow Granahan Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Granahan Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Granahan Investment Management, LLC with notifications on news.